CI & Patent News: 23/11/2010a

1) Vertex Completes New Drug Application for Telaprevir for Hepatitis C (Link)

2) Gilead Sciences Submits New Drug Application to U.S. FDA for Once-Daily Single-Tablet Regimen of Truvada® (emtricitabine and tenofovir disoproxil fumarate)and TMC278 (rilpivirine hydrochloride) for HIV (Link)

3) Wockhardt Ltd. has restarted talks with Abbott Laboratories to sell its nutrition business (Link)

About Guna

Interested to learn things around me
This entry was posted in Daily interesting IP news and tagged , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s